CSL Limited (CSLLY): Price and Financial Metrics

CSL Limited (CSLLY): $93.06

-0.16 (-0.17%)

POWR Rating

Component Grades













Add CSLLY to Watchlist
Sign Up

Industry: Biotech


of 453

in industry

CSLLY Stock Price Chart Interactive Chart >

Price chart for CSLLY

CSLLY Price/Volume Stats

Current price $93.06 52-week high $117.49
Prev. close $93.22 52-week low $90.10
Day low $91.54 Volume 102,900
Day high $93.35 Avg. volume 78,141
50-day MA $104.70 Dividend yield 1.16%
200-day MA $108.33 Market Cap 89.10B

CSL Limited (CSLLY) Company Bio

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

CSLLY Latest News Stream

Event/Time News Detail
Loading, please wait...

CSLLY Latest Social Stream

Loading social stream, please wait...

View Full CSLLY Social Stream

CSLLY Price Returns

1-mo -11.93%
3-mo -18.13%
6-mo -12.12%
1-year -9.62%
3-year 34.21%
5-year 126.68%
YTD -12.04%
2021 -3.06%
2020 14.30%
2019 51.91%
2018 18.56%
2017 52.11%

CSLLY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CSLLY Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8881 seconds.